ESC 2017: Rivaroxaban + Aspirin Is Shown to Improve Outcomes in Patients With Stable Cardiovascular Disease - COMPASS Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.